Search results
PROMOTED
How do worsening heart events dictate the long-term outcomes of patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and can earlier intervention influence the disease trajectory in ATTR-CM? In this new sub-analysis from ATTRibute-CM, recorded onsite at ESC Heart Failure Congress (HFA) 2026, Prof Marianna Fontana (University College London, London, UK) sheds further light onto these…
View more
HFA 2026: Updates on ATTR-CM
Author(s):
Marianna Fontana
,
Added:
3 weeks ago
Video Series
Non-invasive Coronary Functional Tests in ANOCA
Author(s):
Nello Cambise
,
Angelo Giuseppe Marino
,
Fabio De Benedetto
,
et al
Added:
4 months ago
Original Research
Author(s):
Gaetano Antonio Lanza
Added:
1 year ago
Updates on Chronic Coronary Syndrome
Author(s):
Filippo Gurgoglione
,
Giampaolo Niccoli
Added:
1 year ago
Editorial
The Coronary Microcirculation Re-explored
Author(s):
Ahmed Elamin
,
Mustafa Abdimalik
,
Mohanad Abdelrahim
,
et al
Added:
7 months ago
Review Article
Author(s):
Milind Y Desai
Added:
9 months ago
ESC Congress 2025 - ODYSSEY-HCM finds no improvements in patients with non-obstructive cardiomyopathy when treated with mavacamten.Dr Milind Desai (Cleveland Clinic, US) joins us to discuss findings from the ODYSSEY-HCM trial, evaluating the safety, tolerability, and efficacy of mavacamten in patients with symptomatic non-obstructive hypertrophic cardiomyopathy.The ODYSSEY-HCM study was a…
View more
Author(s):
Armin Arbab-Zadeh
,
Michelle Graham
,
Hector M Garcia-Garcia
,
et al
Added:
8 months ago
Separated Vasoreactivity Testing of ACH
Author(s):
Shozo Sueda
,
Tomoki Sakaue
Added:
1 year ago
Expert Opinion
Author(s):
Mackram F Eleid
Added:
7 months ago
Explore advanced strategies for preventing and managing LVOT obstruction in transcatheter mitral valve replacement with Dr Mackram EleidThis presentation, part of Women As One's comprehensive Structural Interventions track, examines of a 90-year-old patient with severe mitral annular calcification, heart failure with preserved ejection fraction, and significant basal septal hypertrophy. Dr Eleid…
View more
Author(s):
Luca Testa
Added:
1 year ago
Dr Luca Testa (IRCCS Policlinico San Donato, IT) discusses the results of the XLIMIT Trial at the EuroPCR 2024 congress in Paris, France.In this video interview, Dr Testa explains the technology behind the XLIMUS® drug-eluting stent (Cardionovum®) and its benefits. He also reviews the XLIMIT Trial, detailing the study design, selection criteria and clinical outcomes.Specifically, the 6 to 9…
View more